Marka Crittenden
Radiation Oncology · Portland, ORNPI 1619187143
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $19,140 of the $19,545 with a category attached, or 97.9%. 6 manufacturers reported payments, led by F. Hoffmann-la Roche AG at 49.0% of the total. 2022 is the largest year on record at $19,292, more than ten times the $240 reported in 2019. Among radiation oncology clinicians in OR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 7 payments — averaging $2792.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- F. Hoffmann-la Roche AG$10K
- Roche Products Limited$10K
- Merck$240
- Johnson & Johnson$125
- GE HealthCare$27
- Siemens Medical Solutions USA, Inc.$13
Across 7 payments — averaging $5917.54 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$41K
What the payments were for
- Consulting fees$19,14098%
- Food & beverage$4052%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| F. Hoffmann-la Roche AG | 1 | $9,570 |
| Roche Products Limited | 1 | $9,570 |
| Merck | 2 | $240 |
| Johnson & Johnson | 1 | $125 |
| GE HealthCare | 1 | $27 |
| Siemens Medical Solutions USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TECENTRIQ$19,140
- MATRIXMANDIBLE$125
- KEYTRUDA$120
How this compares
$19,545 in reported general payments places this provider in the 95th percentile of 93 radiation oncology providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 14 | $250 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Portland
- Steven SeungPortland$11K
- Joshua WalkerPortland$9K
- Andrew KeePortland$7K
- Brandon DyerPortland$4K
- Nima NabavizadehPortland$4K
- Amar SrivastavaPortland$4K
- Re-I ChinPortland$3K
- Akanksha RajeursPortland$2K
- Matthew SolhjemPortland$2K
- Kristina YoungPortland$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.